|
⚲
|
| Keyboard |
| Carter Charles Ross
✚
|
|
|---|---|
| CIK # | 0001779359 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001779359] | |
| 4 | [0001779359] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Carter Charles Ross | |
| Ovid Therapeutics Inc | |
| CERO Therapeutics Holdings Inc | |
| ICAD Inc | |
| GI Dynamics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-06-28 | Grant | 100,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-03-25 | Grant | 395,387 | $0.00 | |
|
ICAD Inc ICAD
Employee Stock Option (right to buy) · derivative
|
2022-01-10 | Grant | 75,000 | $6.24 | 468,000 |
|
ICAD Inc ICAD
Common Stock
|
2021-12-08 | Buy | 7,000 | $7.05 | 49,350 |
|
ICAD Inc ICAD
Employee Stock Option (right to buy) · derivative
|
2021-08-02 | Grant | 75,000 | $0.00 | |
|
GI Dynamics Inc NONE
Stock Option (right to buy) · derivative
|
2021-03-09 | Disposed to issuer | 385,226 | $0.00 | |
|
GI Dynamics Inc ASX:GID
Stock Option (right to buy) · derivative
|
2019-09-19 | Grant | 385,226 | $0.00 |